RAPT Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
RAPT Therapeutics Inc
TickerRAPT
CIK #0001673772
CUSIP75382E109
SectorLife Sciences - Pharmaceutical Preparations
Address561 Eccles Avenue, South San Francisco, CA 94080
Source [EDGAR]
CIK Filing 2011 - 2024
[0001673772] 10-K
[0001673772] 10-Q
[0001673772] 3
[0001673772] 4
[0001673772] 5
[0001673772] 8-K
[0001673772] D
[0001673772] SC 13D
[0001673772] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp RAPT Therapeutics Inc [2023-02-10] 5.72
Redmile Group LLC RAPT Therapeutics Inc [2022-06-03] 0.9
FMR LLC RAPT Therapeutics Inc [2022-02-09] 0.0
BlackRock Inc RAPT Therapeutics Inc [2021-02-02] 5.6
Regents of the University of California RAPT Therapeutics Inc [2021-02-01] 4.489
Perceptive Advisors LLC RAPT Therapeutics Inc [2020-12-14] 5.4
Regents of the University of California RAPT Therapeutics Inc [2020-02-24] 0.0
Price T Rowe Associates Inc /MD/ RAPT Therapeutics Inc [2020-02-14] 5.4
Kleiner Perkins Caufield & Byers XV LLC RAPT Therapeutics Inc [2020-02-13] 15.8
Topspin Fund LP RAPT Therapeutics Inc [2019-11-15] 12.0
Column Group II LP RAPT Therapeutics Inc [2019-11-08] 23.4
Form 3/4/5 Filer 2011 - 2024
RAPT Therapeutics, Inc.
Lyons-Williams Lori
Robbins Wendye
Rieflin William JL
Giordano Michael F
Kozick Linda
Gray Mary Ann
Ho William
Brockstedt Dirk G.
Wong Brian Russell
Young Rodney KB
Ponoi II Management, LLC
Ponoi Capital II, LP
Svennilson Peter
Column Group LLC
Goeddel David V
Column Group II LP
Ponoi Management, LLC
Ponoi Capital LP
Column Group II GP, LP
Kutzkey Tim
Column Group IV, LP
TCG IV GP LLC
Column Group IV-A, LP
Column Group IV GP, LP
Lam Karen C
Kleiner Perkins Caufield & Byers XV, LLC
KPCB XV Founders Fund, LLC
KPCB XV Associates, LLC
Column Group II Management, LP
LG Management, LLC
Topspin Biotech Fund II, L.P.
Guthart Leo
Topspin Fund L.P.
Hall Eric J.
Form 13F Holdings
Firm Period DFND Voting Shares
FMR LLC [2023-03-31] DFND 4,455,603.0 4,455,840.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 642,022.0 3,280,393.0
Column Group LLC [2023-03-31] SOLE 2,680,621.0 2,680,621.0
Perceptive Advisors LLC [2023-03-31] SOLE 2,291,608.0 2,291,608.0
BlackRock Inc. [2023-03-31] SOLE 2,136,495.0 2,171,704.0
State Street Corp [2023-03-31] DFND 1,578,969.0 1,639,046.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 1,516,523.0
Great Point Partners LLC [2023-03-31] DFND 0.0 1,355,151.0
OrbiMed Advisors LLC [2023-03-31] DFND 310,400.0 1,251,070.0
T. Rowe Price Investment Management, Inc. [2023-03-31] SOLE 486,062.0 1,231,783.0
Kingdon Capital Management LLC [2023-03-31] DFND 875,984.0 875,984.0
Morgan Stanley [2023-03-31] DFND 773,280.0 774,175.0
Redmile Group LLC [2023-03-31] SOLE 688,132.0 688,132.0
Cormorant Asset Management LP [2023-03-31] DFND 650,000.0 650,000.0
Deep Track Capital LP [2023-03-31] SOLE 571,233.0 571,233.0
Alphabet Inc. [2023-03-31] DFND 0.0 540,270.0
Geode Capital Management LLC [2023-03-31] DFND 528,555.0 528,555.0
Euclidean Capital LLC [2023-03-31] SOLE 432,900.0 432,900.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 387,222.0 425,627.0
Citadel Advisors LLC [2023-03-31] DFND 374,445.0 374,445.0
Candriam SCA [2023-03-31] SOLE 330,399.0 330,399.0
Nuveen Asset Management LLC [2023-03-31] DFND 326,174.0 326,174.0
Point72 Asset Management LP [2023-03-31] DFND 0.0 325,700.0
Polar Asset Management Partners Inc [2023-03-31] SOLE 315,900.0 315,900.0
Boxer Capital, LLC [2023-03-31] OTR 300,000.0 300,000.0
Deutsche Bank AG [2023-03-31] DFND 5,432.0 295,894.0
Northern Trust Corp [2023-03-31] DFND 17,203.0 286,574.0
Fred Alger Management LLC [2023-03-31] SOLE 196,489.0 196,489.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 194,966.0 194,966.0
Susquehanna International Group LLP [2023-03-31] DFND 49,366.0 192,666.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com